← FDA DRUG APPROVALS

FDA NDA · NDA019940

ACTINEX

Sponsor: UNIV AZ CANCER CTR

APPLICATION
NDA019940
TYPE
NDA
ORIGINAL APPROVAL
1992-09-04
LATEST ACTION
1995-06-14
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

ACTINEXDiscontinued
MASOPROCOL 10% · CREAM · TOPICAL

Approval history

1995-06-14Manufacturing (CMC) · Supplement 1 · standardAP
1992-09-04Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →